Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

‘Caution in use’ alert issued for Inhixa solution for injection

‘Caution in use’ alert issued for Inhixa solution for injection

April 20 2018 A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin...

Views sought on improving health services for people with sensory loss

Views sought on improving health services for people with sensory loss

April 20 2018 Primary care professionals are being asked for views on how to help improve...

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

April 20 2018 Doctors have not been prevented from prescribing over-the counter medicines, but...

Epipen manufacturing delays causing stock shortage

Epipen manufacturing delays causing stock shortage

April 17 2018 A manufacturing delay is causing problems around availability of Epipen (Senior)...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:48
  • ‘Caution in use’ alert issued for Inhixa solution for injection

    ‘Caution in use’ alert issued for Inhixa solution for injection

    Friday, 20 April 2018 16:43
  • Views sought on improving health services for people with sensory loss

    Views sought on improving health services for people with sensory loss

    Friday, 20 April 2018 16:39
  • Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Friday, 20 April 2018 16:31
  • Epipen manufacturing delays causing stock shortage

    Epipen manufacturing delays causing stock shortage

    Tuesday, 17 April 2018 08:53

a mosquito imageNovember 14 2017

Public Health England has changed a number of recommendations in the guidance on reducing the risk of catching malaria.

The latest issue of the Health Protection Report (November 10 2017) summarises the updates, which includes substantial revisions on prevention recommendations for some countries in Central and South America and Southeast Asia, and for Pakistan. Changes include reclassification of risk and routine chemoprophylaxis no longer being recommended. “The focus is now on bite avoidance and risk awareness,” it says.

However, it notes that “much of sub-Saharan Africa remains at high risk for malaria and the advice has not changed.”

For individual countries, recommendations now include additional maps provided by the National Travel Health Network and Centre (NaTHNaC) in collaboration with the PHE Advisory Committee on Malaria Prevention (ACMP). These now show areas and level of risk, and appropriate preventative measures against malaria.

PHE is also asking health professionals to stick to using one resource when advising travellers about malaria. “While acknowledging other sources of advice and guidance on malaria prevention are available, health professionals working in England, Wales or Northern Ireland are advised to use the ACMP guidelines as their preferred resource,” says the HPR.

In addition: “While the focus of these guidelines is on malaria prevention, it should be emphasised that malaria prevention is only one aspect of pre-travel advice. A comprehensive risk assessment-based package of travel health advice should be provided to the traveller.”

Links:
PHE: HPR volume 11 issue 40: news (10 November)        
PHE Guidance ‘Malaria prevention guidelines for travellers from the UK’
NaTHNaC website            

Professional News

April 23 2018 A pilot scheme is highlighting anticipated waiting times for a hospital referral, using an ‘e-traffic light’ system. When a GP is wanting to make the referral, a green light on the...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...